TABLE 1

Characteristics of PAH patients admitted to the ICU

AllIPAHCTD-PAH#Other-PAHp-value
Subjects n102295716
Age upon first admission years58.7±13.653.7±13.563.5±11.950.6±12.8<0.001
Female86 (84.3)27 (93.1)51 (89.5)8 (50.0)<0.001
Race n (White/AA/Hispanic/others)59/39/2/216/12/0/136/20/0/17/7/2/00.05
WHO FC pre-admission n (II/III/IV)24/59/1910/15/412/36/92/8/60.002
Time since PAH diagnosis to first ICU admission months, median (IQR)38.9 (12.4–92.3)64.5 (25.9–147.3)39.5 (11.8–92.1)24.6 (9.7–33.9)0.002
Haemodynamics at PAH diagnosis
RAP mmHg11±612±69±612±70.14
mPAP mmHg45±1454±1439±1250±15<0.001
PCWP mmHg10±410±311±411±40.97
Cardiac output L·min−14.7±1.94.6±2.04.8±1.84.6±2.10.85
Cardiac index L·min−1·m−22.19±0.642.11±0.532.23±0.692.12±0.580.61
PVR Wood units, median (IQR)7.7 (4.8–11.8)10.0 (7.6–14.6)6.7 (3.0–9.6)9.4 (5.3−14.0)0.008
Comorbidities
Coronary artery disease10 (9.8)4 (13.8)4 (7.2)2 (13.0)0.56
Systemic hypertension23 (22.6)8 (27.6)14 (24.6)1 (6.3)0.22
Diabetes mellitus14 (13.7)9 (31.0)3 (5.3)2 (12.5)0.005
Peripheral vascular disease3 (2.9)0 (0)2 (3.5)1 (6.3)0.45
Cerebrovascular disease3 (2.9)0 (0)2 (3.5)1 (6.3)0.45
History of depression9 (8.8)1 (3.5)5 (8.8)3 (18.8)0.68
Charlson comorbidity index
09 (8.8)8 (27.6)0 (0)1 (6.3)<0.001
110 (9.8)4 (13.8)6 (10.4)0 (0)
215 (14.7)6 (20.7)7 (12.3)2 (12.5)
≥368 (66.7)11 (37.9)44 (77.2)13 (81.2)

Data are expressed as mean±sd and n (%) unless otherwise indicated. PAH: pulmonary arterial hypertension; ICU: intensive care unit; IPAH: idiopathic PAH; CTD-PAH: connective tissue diseases PAH; AA: African American; WHO FC: World Health Organization functional class; IQR: interquartile range; RAP: right atrial pressure; mPAP: mean pulmonary artery pressure; PCWP: pulmonary capillary wedge pressure; PVR: pulmonary vascular resistance. #: CTD-PAH includes: 46 scleroderma-associated PAH (SSc-PAH) patients and 11 patients with other CTD-associated PAH conditions; : other-PAH includes: CHD-PAH (3), portopulmonary hypertension-PAH (6) and HIV-associated PAH (7) patients.